DYNE THERAPEUTICS INC's ticker is DYN and the CUSIP is 26818M108. A total of 118 filers reported holding DYNE THERAPEUTICS INC in Q2 2023. The put-call ratio across all filers is 4.08 and the average weighting 0.8%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2023 | $892 | -3.3% | 99,574 | +21.5% | 0.00% | 0.0% |
| Q2 2023 | $922 | +149.2% | 81,971 | +155.5% | 0.00% | – |
| Q1 2023 | $370 | +31.2% | 32,088 | +32.4% | 0.00% | – |
| Q4 2022 | $282 | -99.9% | 24,243 | +41.9% | 0.00% | – |
| Q3 2022 | $217,000 | -60.3% | 17,079 | -78.5% | 0.00% | – |
| Q2 2022 | $547,000 | +195.7% | 79,499 | +314.4% | 0.00% | – |
| Q1 2022 | $185,000 | – | 19,186 | – | 0.00% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Vida Ventures Advisors, LLC | 2,960,046 | $20,335,000 | 17.18% |
| MPM ASSET MANAGEMENT LLC | 4,951,303 | $34,015,000 | 14.35% |
| Atlas Venture Life Science Advisors, LLC | 8,934,902 | $61,383,000 | 10.26% |
| INTERNATIONAL BIOTECHNOLOGY TRUST PLC | 3,865 | $562,568,000 | 5.87% |
| Logos Global Management LP | 2,900,000 | $19,923,000 | 3.66% |
| Deep Track Capital, LP | 3,500,000 | $24,045,000 | 1.58% |
| HighVista Strategies LLC | 241,867 | $1,662,000 | 1.00% |
| Monashee Investment Management LLC | 319,536 | $2,195,000 | 0.80% |
| RA Capital Management | 2,805,045 | $19,271,000 | 0.51% |
| Vivo Capital, LLC | 577,642 | $3,968,000 | 0.40% |